PUNJABCHEM - Punjab Chemicals
📢 Recent Corporate Announcements
Punjab Chemicals and Crop Protection Limited has officially released the transcript of its earnings conference call for the third quarter and nine months ended December 31, 2025. The call, originally held on January 29, 2026, provides management's detailed perspective on the company's financial performance and operational updates. This disclosure is a standard regulatory requirement under SEBI (LODR) Regulations, 2015. Investors can now access the full discussion to evaluate management's outlook on the agrochemical sector.
- Official transcript of the Q3 & 9M FY26 earnings call held on January 29, 2026, is now available.
- The document covers financial performance for the period ending December 31, 2025.
- Disclosure made in compliance with Regulation 30 and 46 of SEBI (LODR) Regulations.
- Transcript is accessible via the company's website for detailed management commentary.
Punjab Chemicals & Crop Protection Limited has scheduled a one-on-one physical meeting with institutional investor Svan Investments. The meeting is set to take place on February 3, 2026, at 3:00 PM. The company has explicitly stated that the discussions will be based on publicly available information and no unpublished price-sensitive information (UPSI) will be shared. This is a routine regulatory disclosure under SEBI (LODR) Regulations, 2015.
- One-on-one physical meeting scheduled with Svan Investments.
- Interaction date set for February 3, 2026, at 3:00 PM.
- Compliance with Regulation 30 of SEBI (LODR) Regulations, 2015.
- Company confirms no unpublished price-sensitive information (UPSI) will be discussed.
Punjab Chemicals & Crop Protection Limited has made the audio recording of its Q3 and 9M FY26 earnings call available to the public. The call, held on January 29, 2026, discussed the unaudited standalone and consolidated financial results for the period ended December 31, 2025. This filing is a routine regulatory requirement under SEBI LODR Regulations to ensure transparency for shareholders. Investors can access the recording on the company's official website to hear management's detailed commentary on performance.
- Audio recording of the Q3 & 9M FY26 earnings call is now accessible via the company website.
- The call followed the announcement of financial results for the quarter and nine months ended December 31, 2025.
- Compliance with SEBI Regulation 30 and 46 regarding disclosure of institutional meets.
- The recording provides management insights into both standalone and consolidated performance.
Punjab Chemicals reported a strong Q3 FY26 performance with revenue growing 15.3% YoY to ₹246.6 Cr, driven by improved domestic and export demand. Profitability saw a significant boost as PAT surged 127.7% YoY to ₹13.8 Cr, while EBITDA margins expanded to 12.0% from 9.0% in the previous year. The company is aggressively expanding its product pipeline with three new MOUs signed for exports and ₹60 Cr capex earmarked for capacity expansion. For the 9M FY26 period, revenue reached ₹821.2 Cr with a PAT of ₹53.0 Cr, representing a 66.2% YoY growth.
- Q3 FY26 Revenue grew 15.3% YoY to ₹246.6 Cr, while 9M FY26 Revenue rose 17.6% to ₹821.2 Cr.
- EBITDA for the quarter increased 53.5% YoY to ₹29.6 Cr, with margins improving to 12.0%.
- PAT witnessed a massive 127.7% YoY growth to ₹13.8 Cr in Q3 FY26.
- Signed 3 MOUs for export-oriented products and earmarked ₹60 Cr for new manufacturing blocks.
- Commercial production trials for 4 new products are underway for Q4 FY26.
Punjab Chemicals reported a strong year-on-year performance for Q3 FY26, with standalone revenue growing 15% to ₹245.9 crore compared to ₹213.6 crore in the previous year. Net profit (PAT) saw a significant jump of 110% YoY to ₹13.99 crore, although it declined sequentially from ₹17.39 crore in Q2 FY26. The company recognized an exceptional expense of ₹2.08 crore due to the implementation of New Labour Codes. For the nine-month period, the company demonstrated robust growth with PAT increasing by 59% to ₹51.45 crore.
- Revenue from operations grew 15.1% YoY to ₹245.92 crore in Q3 FY26.
- Net Profit (PAT) surged 110% YoY to ₹13.99 crore, with EPS rising to ₹11.41 from ₹5.42.
- Nine-month (9M FY26) PAT stands at ₹51.45 crore, a 59.2% increase over the previous year.
- Exceptional item of ₹2.08 crore recorded towards provision for employee benefits under New Labour Codes.
- Interest income of ₹1.86 crore accrued on income tax refunds during the quarter following favorable ITAT orders.
Punjab Chemicals & Crop Protection Limited has scheduled its post-results conference call for the third quarter and nine months ended December 31, 2025 (FY26). The call is set for January 29, 2026, at 5:00 PM IST and will be hosted by Antique Stock Broking Limited. Senior management, including the Managing Director, CEO, and CFO, will be present to discuss financial performance and the business outlook. This call provides a platform for investors to seek clarity on the company's operational performance and future growth strategies.
- Conference call for Q3 and 9M FY26 results scheduled for January 29, 2026, at 5:00 PM IST.
- Management representation includes MD Shalil Shroff, CEO Vinod Gupta, and CFO Devender Gupta.
- The call is organized by Antique Stock Broking Limited with universal dial-in numbers +91 22 6280 1342 / +91 22 7115 8243.
- International toll-free access available for major regions including USA, UK, Singapore, and Hong Kong.
Punjab Chemicals and Crop Protection Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The filing, issued by the Registrar and Transfer Agent (RTA) Alankit Assignments Limited, covers the quarter ended December 31, 2025. It confirms that physical share certificates received for dematerialization were verified, cancelled, and the depository's name was updated in the records. This is a standard procedural filing required for all listed companies in India to maintain shareholding records.
- Compliance certificate submitted for the quarter ended December 31, 2025.
- Issued by Alankit Assignments Limited, the company's Registrar and Transfer Agent.
- Confirms processing and cancellation of physical share certificates for dematerialization.
- Ensures that the securities are listed on the Stock Exchanges (BSE and NSE) and records are updated.
- Standard regulatory filing with no impact on business operations or financial health.
Punjab Chemicals & Crop Protection Limited has announced the closure of its trading window for all designated persons starting January 1, 2026. This action is taken in compliance with SEBI Insider Trading regulations ahead of the announcement of financial results for the quarter and nine months ending December 31, 2025. The window will remain closed until 48 hours after the Un-audited Standalone and Consolidated Financial Results are declared. The specific date for the Board Meeting to approve these results will be communicated separately in the future.
- Trading window closure effective from January 1, 2026, for all designated persons and their relatives.
- Closure is related to the upcoming Q3 and nine-month financial results ending December 31, 2025.
- The restriction will be lifted 48 hours after the official declaration of the financial results.
- The company will announce the specific Board Meeting date for result approval in due course.
Punjab Chemicals and Crop Protection Limited has appointed Mr. Devender Gupta as the new Chief Financial Officer, effective December 16, 2025. He fills the vacancy created by the resignation of the previous CFO, Mr. Vikash Khanna. Mr. Gupta is a Chartered Accountant with over 28 years of experience in financial management, including fund raising and M&A. His previous experience includes senior roles at Panacea Biotec and Jubilant Lifesciences, bringing significant industry expertise to the company.
- Mr. Devender Gupta appointed as CFO effective December 16, 2025
- Brings over 28 years of experience in financial management, fund raising, and M&A
- Previously worked with reputable firms like Panacea Biotec and Jubilant Lifesciences
- Appointment fills the vacancy caused by the resignation of Mr. Vikash Khanna
- Expertise includes ERP implementation, strategic planning, and investor relations
Financial Performance
Revenue Growth by Segment
Agrochemicals contribute 70-80% of total revenue, while CRAMS (Contract Research and Manufacturing Services) accounts for 60-70% of revenue. Overall revenue from operations declined 4% from INR 934.23 Cr in FY24 to INR 900.52 Cr in FY25. However, Q1 FY26 showed a 37% YoY recovery to INR 319.51 Cr, and Q2 FY25 grew 5.4% YoY to INR 255.2 Cr.
Geographic Revenue Split
The company maintains a wide geographical presence across domestic and export markets. Q2 FY25 growth was driven by improvements in both domestic and export sales, though specific percentage splits per region are not disclosed in the provided documents.
Profitability Margins
Gross margins for Q2 FY25 stood at 39.5%, improved by product mix. Net Profit Margin (PAT) declined from 5.74% in FY24 to 4.32% in FY25 due to lower absorption of fixed costs and pricing pressures. Operating Profit Margin was 8.38% in FY25 compared to 10.02% in FY24.
EBITDA Margin
EBITDA margin was 11.17% in FY25, a decrease from 12.42% in FY24. EBITDA for FY25 was INR 100.62 Cr, down 13.3% from INR 116.08 Cr in FY24. Q2 FY25 EBITDA margin was 10.3% (INR 26.2 Cr).
Capital Expenditure
The company is investing in new blocks and plant upgrades planned for FY26 to support rising demand. Non-current investments increased to INR 1.57 Cr in FY25 from INR 1.44 Cr in FY24. Debt-funded capex is monitored by rating agencies to ensure it does not weaken the financial risk profile.
Credit Rating & Borrowing
CARE reaffirmed ratings at CARE BBB+; Stable / CARE A2 in September 2025. CRISIL reaffirmed 'Crisil BBB+/Stable' in August 2025. Interest coverage ratio remained healthy at 5.57x in FY25 compared to 5.46x in FY24.
Operational Drivers
Raw Materials
Agrochemical technicals and intermediates; specific chemical names not listed, but cost of material consumed represents 65.2% of total revenue (INR 587 Cr).
Import Sources
Sourced from diverse geographies including China (major pricing influencer) and local suppliers in India to mitigate supply chain risks.
Key Suppliers
Not specifically named, but the company is actively developing local Indian suppliers to reduce dependency on imports.
Capacity Expansion
Planned upgrades and new blocks are scheduled for FY26 to boost revenue and profitability by supporting rising demand for new product launches.
Raw Material Costs
Cost of material consumed increased 6% YoY to INR 587 Cr in FY25 (from INR 553 Cr) due to changes in pricing and product mix. This represents a significant portion of the INR 844 Cr total expenses.
Manufacturing Efficiency
Capacity utilization metrics not explicitly stated, but the company noted lower absorption of fixed costs due to flat revenues in FY25, impacting margins.
Logistics & Distribution
Higher freight costs were cited as a reason for lower PBILDT margins in 9MFY25.
Strategic Growth
Expected Growth Rate
37%
Growth Strategy
Growth is targeted through a strong product pipeline, new block commissions in FY26, and a focus on the CRAMS segment (60-70% of revenue). The company is leveraging long-term relationships with global clients and investing in R&D for green chemistry to stay ahead in product development.
Products & Services
Agrochemicals (pesticides, herbicides), specialty chemicals, and industrial chemicals. The company also provides CRAMS services for global agrochemical players.
Brand Portfolio
Punjab Chemicals and Crop Protection Limited (PCCPL); SD Agchem (Europe) NV (subsidiary).
New Products/Services
New product launches are supported by an inventory buildup of INR 222 Cr; these are expected to boost revenue and profitability in FY26.
Market Expansion
The company has a wide geographical presence and is focusing on increasing plant capacity through upgrades to support rising global and domestic demand.
Strategic Alliances
Originally promoted in association with Excel Industries Limited and Punjab State Industrial Development Corporation (PSIDC).
External Factors
Industry Trends
The global crop protection industry was valued at USD 64.18 billion in FY24. Trends include a shift toward green chemistry and sustainable solutions due to augmented environmental awareness and regulatory scrutiny.
Competitive Landscape
Faces intense competition from leading global and domestic agrochemical companies with strong brand recognition and robust R&D, as well as low-cost Chinese producers.
Competitive Moat
Moat is built on long-standing relationships with global agrochemical majors and a high share of CRAMS business (60-70%), which provides better revenue visibility compared to pure generic manufacturing.
Macro Economic Sensitivity
Highly sensitive to agricultural cycles and monsoon patterns which dictate domestic demand for agrochemicals.
Consumer Behavior
Increased demand for greener alternatives and sustainable chemical solutions is driving the company to innovate in green chemistry.
Geopolitical Risks
Trade dynamics with China are critical, as Chinese oversupply impacts global pricing and revenue realisation for Indian manufacturers.
Regulatory & Governance
Industry Regulations
Subject to Section 148 of the Companies Act, 2013 for cost audits. Operations are influenced by environmental awareness and regulatory shifts toward sustainable chemical production.
Environmental Compliance
The company is focusing on solvent recovery and minimized carbon emissions to meet evolving environmental regulations and consumer needs.
Risk Analysis
Key Uncertainties
Pricing pressure from China and monsoon dependency are the primary uncertainties, with the potential to impact margins by 1-2% based on historical volatility.
Geographic Concentration Risk
While geographically diversified, the company is heavily reliant on the global agrochemical market's stability.
Third Party Dependencies
Significant dependency on three major customers for over 50% of revenue, making the company vulnerable to the growth plans of these specific clients.
Technology Obsolescence Risk
Risk of products becoming obsolete due to environmental regulations; mitigated by R&D focus on green chemistry and new product pipelines.
Credit & Counterparty Risk
Trade receivables rose to INR 235 Cr in FY25 from INR 197 Cr; the trade receivable turnover ratio slowed to 4.16 from 5.48, indicating a slight increase in credit exposure.